Sophia Genetics(US:SOPH)2025-11-04 13:00Company Overview and Platform - SOPHiA GENETICS' AI platform SOPHiA DDM™ is used by over 800 healthcare institutions globally[7] - The platform analyzes over 350,000 patients per year[8, 21] and has analyzed over 2 million profiles since its inception[8] - The company has invested over $400 million since its inception to develop AI Factories and proprietary algorithms[21, 53] Market Trends and Data Analysis - Healthcare data accounts for 30% of all data generated globally[16] - In Q3 2025, SOPHiA GENETICS analyzed over 99,000 genomic analyses[31] - Total data processed on SOPHiA DDM™ has seen compounded growth of over 50% since 2021[38] Financial Performance and Outlook - The company's revenue for 2024 was $65.2 million[56] - Revenue is expected to be in the range of $75 million to $77 million in 2025, representing year-over-year growth of 15% to 18%[59] - Adjusted gross margin was 72.8% in 2024[59] and 73.1% in Q3 2025[63] - The company has a cash balance of $81.6 million as of Q3 2025[63]